Clinical Practice Guidelines (CPG) on EBMonFHIR
1.0.2 - qa-preview

This page is part of the CPG-on-EBMonFHIR Implementation Guide (1.0.2).

PlanDefinition: Dexamethasone Application (Experimental)

Official URL: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/example/covid19-ventilated-patients-dexamethasone-application-plan Version: 4.0
Active as of 2021-12-12 Responsible: CPGonEBMonFHIR Computable Name: Dexamethasone_Application

Application of Dexamethasone: 6 mg once per day for 10 days p.o. or i.v. for ventilated COVID-19 patients

Generated Narrative: PlanDefinition COVID19VentilatedPatientsDexamethasoneApplicationPlan

knowledgeCapability: computable

knowledgeRepresentationLevel: structured

partOf: Dexamethasone Application

Action Combination Method

  • method: Exactly
  • threshold: 1

url: PlanDefinition Dexamethasone Application in ventilated COVID-19 patients

version: 4.0

name: Dexamethasone_Application

title: Dexamethasone Application in ventilated COVID-19 patients

type: ECA Rule

status: Active

experimental: true

subject: Population_COVID19_Ventilated

date: 2021-12-12

publisher: CPGonEBMonFHIR

description:

Application of Dexamethasone: 6 mg once per day for 10 days p.o. or i.v. for ventilated COVID-19 patients

copyright:

action

code: Administration of substance (procedure)

definition: DexamethasoneApplicationActionOral

action

code: Administration of substance (procedure)

definition: DexamethasoneApplicationActionIntravenous